Ann Arbor-based Michigan Medicine is projected to finish fiscal 2025 with an operating income of $233.5 million (2.7% operating margin).
The projected results for the year ending June 30 were presented to the University of Michigan Board of Regents June 12, according to a news release.
The 11-hospital system is projected to end the year with total operating revenue of $8.5 billion.
The system exceeded its expected financial performance for the year due to greater-than-expected patient volumes across its statewide network, according to the release. The system had planned for a 1.7% operating margin in 2025.
“Our success in fiscal 2025 was rooted in our BASE + Growth priorities: Belonging, Access, Safety, Experience and Growth,” Michigan Medicine CEO David Miller, MD, said in the release. “Our team’s commitment and dedication to those goals results in a successful, integrated, cost-effective and high-quality health care system.”
The Regents approved the health system’s budget for the fiscal year that begins July 1. Michigan Medicine is aiming for a 1.7% operating margin in 2026.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
